ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	20/159	157/7206	1.63721002569e-10
ko04658	Th1 and Th2 cell differentiation	15/159	96/7206	2.06319167382e-09
ko04060	Cytokine-cytokine receptor interaction	20/159	191/7206	5.49440123609e-09
ko05162	Measles	16/159	120/7206	6.35858801654e-09
ko04380	Osteoclast differentiation	16/159	134/7206	3.19139344526e-08
ko04659	Th17 cell differentiation	14/159	106/7206	6.68674217208e-08
ko04660	T cell receptor signaling pathway	15/159	124/7206	7.38306224394e-08
ko05164	Influenza A	17/159	167/7206	1.26600243148e-07
ko04064	NF-kappa B signaling pathway	13/159	96/7206	1.49079412739e-07
ko04623	Cytosolic DNA-sensing pathway	9/159	41/7206	1.89234999872e-07
ko05161	Hepatitis B	17/159	173/7206	2.12139286296e-07
ko04620	Toll-like receptor signaling pathway	13/159	100/7206	2.43347275659e-07
ko04668	TNF signaling pathway	14/159	120/7206	3.24273089403e-07
ko04662	B cell receptor signaling pathway	12/159	88/7206	4.24150713361e-07
ko05168	Herpes simplex infection	17/159	182/7206	4.4128842167e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	16/159	191/7206	4.16617062505e-06
ko05160	Hepatitis C	14/159	153/7206	6.17990408355e-06
ko04622	RIG-I-like receptor signaling pathway	9/159	62/7206	7.37246757432e-06
ko04217	Necroptosis	14/159	178/7206	3.48754833591e-05
ko04210	Apoptosis	14/159	180/7206	3.94901789422e-05
ko05166	HTLV-I infection	18/159	292/7206	7.02847364147e-05
ko05145	Toxoplasmosis	11/159	126/7206	9.74533163419e-05
ko04630	Jak-STAT signaling pathway	11/159	132/7206	0.000148164088572
ko05169	Epstein-Barr virus infection	14/159	206/7206	0.000170049161652
ko05321	Inflammatory bowel disease (IBD)	7/159	56/7206	0.000208641149194
ko05140	Leishmaniasis	8/159	75/7206	0.000226696493177
ko05152	Tuberculosis	13/159	187/7206	0.000233741421467
ko04650	Natural killer cell mediated cytotoxicity	9/159	97/7206	0.000268857588854
ko05131	Shigellosis	8/159	82/7206	0.000420358953216
ko05340	Primary immunodeficiency	5/159	30/7206	0.000447836581629
ko04611	Platelet activation	11/159	163/7206	0.000911454660301
ko05150	Staphylococcus aureus infection	5/159	36/7206	0.00106492575261
ko04672	Intestinal immune network for IgA production	5/159	37/7206	0.00120967120557
ko04062	Chemokine signaling pathway	12/159	201/7206	0.00156545596594
ko05142	Chagas disease (American trypanosomiasis)	9/159	130/7206	0.00223268335773
ko05215	Prostate cancer	8/159	111/7206	0.00303955683642
ko05323	Rheumatoid arthritis	7/159	89/7206	0.00337938941736
ko05212	Pancreatic cancer	6/159	83/7206	0.00979592443829
ko05220	Chronic myeloid leukemia	6/159	85/7206	0.0109513581591
ko04657	IL-17 signaling pathway	6/159	87/7206	0.0122002788575
ko04920	Adipocytokine signaling pathway	6/159	89/7206	0.0135463638914
ko05330	Allograft rejection	3/159	24/7206	0.0151858761414
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/159	92/7206	0.0157554624728
ko04810	Regulation of actin cytoskeleton	12/159	264/7206	0.0160744970967
ko04010	MAPK signaling pathway	14/159	321/7206	0.0168157025391
ko05144	Malaria	4/159	45/7206	0.0168533159844
ko04666	Fc gamma R-mediated phagocytosis	7/159	122/7206	0.018014795131
ko00511	Other glycan degradation	3/159	26/7206	0.0188928748502
ko04624	Toll and Imd signaling pathway	4/159	49/7206	0.0224030598172
ko05134	Legionellosis	5/159	74/7206	0.0233388344601
ko05320	Autoimmune thyroid disease	3/159	29/7206	0.0253101702744
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/159	135/7206	0.0294373498189
ko04610	Complement and coagulation cascades	5/159	79/7206	0.0299380149223
ko05416	Viral myocarditis	4/159	55/7206	0.0326055730701
ko04917	Prolactin signaling pathway	5/159	87/7206	0.0427412984887
ko05133	Pertussis	5/159	87/7206	0.0427412984887
ko00073	Cutin, suberine and wax biosynthesis	1/159	2/7206	0.043646024797
ko04670	Leukocyte transendothelial migration	7/159	151/7206	0.0491961091676